Latest Asx News

Page 116 of 1399
LTR Pharma has secured ethics approval for its Phase II SPONTAN clinical trial, focusing on pharmacokinetics and dosing in men aged 65 and older. Recruitment begins early 2026 with initial results expected mid-year.
Ada Torres
Ada Torres
3 Dec 2025
Nexsen Limited has appointed internationally acclaimed surgeon-scientist Professor Shekhar Kumta to its board, aiming to fast-track clinical validation and regulatory approval for its rapid diagnostic platforms ahead of a planned 2026 market entry.
Ada Torres
Ada Torres
3 Dec 2025
White Cliff Minerals has identified multiple high-priority copper targets along the 10km Teshierpi Fault Zone at its Rae Copper Project in Nunavut, Canada, following a comprehensive 2025 airborne electromagnetic survey. The findings extend known mineralisation at Danvers and set the stage for follow-up drilling in early 2026.
Maxwell Dee
Maxwell Dee
3 Dec 2025
Prairie Lithium has completed critical groundwork at its Canadian lithium brine project, setting the stage for construction and commercial operations in 2026 amid rising lithium prices.
Maxwell Dee
Maxwell Dee
3 Dec 2025
Transurban Group has announced a 34.0 cents per stapled security interim distribution for the half-year ending December 2025, maintaining its FY26 distribution guidance at 69.0 cents. The Distribution Reinvestment Plan will operate without a discount, signaling steady confidence amid ongoing macroeconomic uncertainties.
Nora Hopper
Nora Hopper
3 Dec 2025
Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.
Ada Torres
Ada Torres
3 Dec 2025
Phoslock Environmental Technologies is set to resume production at its Changxing factory after a four-year halt, signaling renewed confidence in market demand and operational stability.
Maxwell Dee
Maxwell Dee
3 Dec 2025
QuickFee Limited has completed a $28.5 million capital return following the sale of its US Pay Now and Connect businesses, while updating its dividend policy to target regular shareholder cash distributions starting in FY26.
Claire Turing
Claire Turing
3 Dec 2025
Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.
Ada Torres
Ada Torres
3 Dec 2025
Odyssey Gold has reported strong reverse circulation drilling results at its Tuckanarra Project, reinforcing the existing resource model and advancing plans for a resource upgrade. The Highway Deposit continues to demonstrate promising grade continuity and open pit potential.
Maxwell Dee
Maxwell Dee
3 Dec 2025
Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.
Ada Torres
Ada Torres
3 Dec 2025
Hazer Group has extended its collaboration with South Korean steel giant POSCO to further integrate its clean hydrogen and low-emissions graphite technology into low-carbon steel production.
Victor Sage
Victor Sage
3 Dec 2025